000 | 01645 a2200445 4500 | ||
---|---|---|---|
005 | 20250517182228.0 | ||
264 | 0 | _c20180613 | |
008 | 201806s 0 0 eng d | ||
022 | _a1573-8221 | ||
024 | 7 |
_a10.1007/s10517-017-3894-8 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMaltseva, D V | |
245 | 0 | 0 |
_aElimination of a Viscumin-Ferromagnetic Nanoparticles Conjugate from the Tumor Nodule in Mice. _h[electronic resource] |
260 |
_bBulletin of experimental biology and medicine _cOct 2017 |
||
300 |
_a745-748 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdenocarcinoma _xdiagnostic imaging |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xpharmacokinetics |
650 | 0 | 4 |
_aBreast Neoplasms _xdiagnostic imaging |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aDrug Carriers _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Intralesional |
650 | 0 | 4 | _aInjections, Subcutaneous |
650 | 0 | 4 | _aMagnetic Resonance Imaging |
650 | 0 | 4 |
_aMagnetite Nanoparticles _xadministration & dosage |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, SCID |
650 | 0 | 4 |
_aRibosome Inactivating Proteins, Type 2 _xpharmacokinetics |
650 | 0 | 4 |
_aToxins, Biological _xpharmacokinetics |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aNikulin, S V | |
700 | 1 | _aSergeeva, N S | |
700 | 1 | _aTonevitskaya, S A | |
700 | 1 | _aSakharov, D A | |
773 | 0 |
_tBulletin of experimental biology and medicine _gvol. 163 _gno. 6 _gp. 745-748 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10517-017-3894-8 _zAvailable from publisher's website |
999 |
_c27715618 _d27715618 |